More AMI News – Page 18
-
NewsDorothy Jones Prize winner to be announced at Applied Microbiology International Awards 2022
The winner of the Dorothy Jones Prize will be announced at theApplied Microbiology International Awards 2022 later this month.
-
NewsWinner of WH Pierce Prize will be announced at Applied Microbiology International Awards 2022
The winner of the WH Pierce Prize is due to be announced later this month at the Applied Microbiology International Awards 2022.
-
NewsGold mine bacterium can clean arsenic-polluted wastewater within days
A bacterium found in a former gold mine in Poland can clean up industrial wastewater polluted with arsenic, selenium and metals within days, researchers have discovered.
-
NewsGull droppings undermine efforts to control spread of colistin-resistance genes
Gull droppings at beaches in the Porto region of Portugal are riddled with bacteria that are resistant to the ‘last-resort’ antibiotic colistin, undermining efforts in the livestock sector to reduce colistin-resistance, according to a paper published in Environmental Microbiology, an Applied Microbiology International publication. Researchers at the ...
-
NewsThe countdown is on for the Applied Microbiology International Awards 2022
The Applied Microbiology International Awards 2022 will be held at the Illuminate at the Science Museum on 29 November 2022 - the first event held by Applied Microbiology International (AMI) under their new branding.
-
NewsWelcome to the launch of The Microbiologist
With a fresh new team who are enthused about communicating all things microbiology, our user-friendly online magazine will deliver the very latest news in microbiology, including exclusive content for Applied Microbiology International (AMI) members and daily updates on research and policy developments.
-
NewsAMI pitches Government to develop pathway to phage therapy
Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.